PMID: Summary Keywords autoimmune diseases, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, incretin-based therapy, psoriasis, real-world evidence Citation Chiang Y-L, Li T-H, Fang Y-W, Liu Y-F, Wu J and Tsai M-H (2026) Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation
In a published study, researchers measured GLP-1 levels in the peritoneal fluid of women with and without endometriosis
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimers disease
If you're curious about GLP-1s, we'll give you a clear picture of benefits and trade-offs and help you build a plan that prioritizes safety and resultsstarting with what works best today
Adding fruit can help hydrate you